(Q43094385)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20401651%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Inhibition of monoamine oxidase activity by cannabinoids (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20401651%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20401651%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Zdenek Fisar

series ordinal

1

1 reference

13 November 2017

18 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20401651%20AND%20SRC:MED&resulttype=core&format=json

Naunyn-Schmiedeberg's Archives of Pharmacology

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20401651%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20401651%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20401651%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

563-572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20401651%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00210-010-0517-6

31 January 2020

exact match

0 references

cites work

Effects of long-term treatment with dicyclic, tricyclic, tetracyclic, and noncyclic antidepressant drugs on monoamine oxidase activity in mouse brain.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-010-0517-6

Distribution of tritium labelled Δ1‐tetrahydrocannabinol in the rat brain following intraperitoneal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-010-0517-6

THC can be detected in brain while absent in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-010-0517-6

Cannabis extract, but not Δ1-tetrahydrocannabinol, inhibits human brain and liver monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-010-0517-6

Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-010-0517-6

Endocannabinoid system and synaptic plasticity: implications for emotional responses

21 January 2018

1 reference

12 December 2020

Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors

1 reference

12 December 2020

Effect of cannabinoids on the activity of monoamine oxidase in normal human platelets

1 reference

12 December 2020

Endocannabinoid-mediated control of synaptic transmission

1 reference

12 December 2020

Reactive oxygen species production by monoamine oxidases in intact cells

1 reference

12 December 2020

Phytocannabinoids and endocannabinoids

1 reference

12 December 2020

Chronic Delta9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex

1 reference

12 December 2020

Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.

1 reference

12 December 2020

Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy

1 reference

12 December 2020

The therapeutic potential of monoamine oxidase inhibitors

1 reference

12 December 2020

Critical role of the endocannabinoid system in the regulation of food intake and energy metabolism, with phylogenetic, developmental, and pathophysiological implications

1 reference

12 December 2020

Cannabinoid-induced alterations in brain disposition of drugs of abuse

1 reference

12 December 2020

Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories

1 reference

12 December 2020

Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain

1 reference

12 December 2020

Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta

1 reference

12 December 2020

Influence of marihuana on cellular structures and biochemical activities

1 reference

12 December 2020

Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors

1 reference

12 December 2020

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

1 reference

12 December 2020

Effect of cannabis extract on the uterine monoamine oxidase activity of normal and estradiol treated rats

1 reference

12 December 2020

cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties

1 reference

12 December 2020

Distribution of antidepressants between plasma and red blood cells.

1 reference

12 December 2020

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

1 reference

12 December 2020

Platelet monoamine oxidase activity in alcoholics, alcoholics with drug dependence, and cocaine addicts.

1 reference

12 December 2020

inhibition of human platelet monoamine oxidase by phenothiazine derivatives

1 reference

12 December 2020

Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats.

1 reference

12 December 2020

Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases

1 reference

12 December 2020

Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.

1 reference

12 December 2020

Impairments in endocannabinoid signaling and depressive illness

1 reference

12 December 2020

Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents.

1 reference

12 December 2020

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease

1 reference

12 December 2020

Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex--involvement of Na(+)/K(+)-ATPase

1 reference

12 December 2020

Multiple catalytic sites of rat brain mitochondrial monoamine oxidase

1 reference

12 December 2020

The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants

1 reference

12 December 2020

Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.

1 reference

12 December 2020

Monoamine oxidases: to inhibit or not to inhibit

1 reference

12 December 2020

The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction

1 reference

12 December 2020

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

12 December 2020

Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders

1 reference

12 December 2020

Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase

1 reference

12 December 2020

Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: application to nitric oxide synthase

1 reference

12 December 2020

Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies

1 reference

12 December 2020

Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness

1 reference

12 December 2020

Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain

1 reference

12 December 2020

Interaction of psychotropic drugs with monoamine oxidase in rat brain

1 reference

12 December 2020

Effect of cannabinoids on platelet serotonin uptake.

1 reference

12 December 2020

Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death

1 reference

12 December 2020

Action of delta9-tetrahydrocannabinol on membrane-bound monoamine oxidase activity.

1 reference

12 December 2020

Effect of delta 9-tetrahydrocannabinol on monoamine oxidase activity in bovine eye tissues, in vitro

1 reference

12 December 2020

Serotonergic vulnerability and depression: assumptions, experimental evidence and implications.

1 reference

12 December 2020

Delta-9-tetrahydrocannabinol accumulation, metabolism and cell-type-specific adverse effects in aggregating brain cell cultures

1 reference

12 December 2020

Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver

1 reference

12 December 2020

Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

The endocannabinoid system as an emerging target of pharmacotherapy

1 reference

12 December 2020

Substrate specificity of the different forms of monoamine oxidase in rat liver mitochondria

1 reference

12 December 2020

Acute and chronic effects of tetrahydrocannabinols on monoamide oxidase activity: possible vehicle/tetrahydrocannabinol interactions

1 reference

12 December 2020

Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation.

1 reference

12 December 2020

Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress

1 reference

12 December 2020

Imipramine distribution among red blood cells, plasma and brain tissue.

1 reference

12 December 2020

Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis

1 reference

12 December 2020

Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage.

1 reference

12 December 2020

The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian species

1 reference

12 December 2020

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

12 December 2020

Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain

1 reference

12 December 2020

CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2.

1 reference

12 December 2020